A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Phase 3
125
about 2.4 years
12–17
15 sites in CA, CT, GA +9
What this study is about
Researchers are testing a treatment called orforglipron versus a placebo in adolescents with obesity or overweight and related health problems. The trial will last about 18 months.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Orforglipron
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Percent Change from Baseline in Body Mass Index (BMI)
Secondary: Change from Baseline in BMI, Change from Baseline in Body Weight, Change from Baseline in Body Weight Percentile, Change from Baseline in Diastolic Blood Pressure, Change from Baseline in Fasting Glucose, Change from Baseline in Systolic Blood Pressure, Change from Baseline in Waist Circumference, Change in Impact of Weight on Quality of Life (IWQOL)-Kids Total and Domain Scores
Endocrinology